[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100612219":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":16,"locations":22,"responsibleParty":164,"collaborators":166,"id":170,"slug":171,"hasResults":172,"nctId":173,"briefTitle":174,"officialTitle":175,"acronym":7,"eligibilityCriteria":176,"healthyVolunteers":172,"sex":177,"minAge":178,"maxAge":7,"enrollmentInfo":7,"targetDuration":7,"studyType":179,"phases":7,"briefSummary":180,"conditions":181,"keywords":191,"overallStatus":25,"whyStopped":7,"lastUpdateSubmitDate":207,"lastUpdatePostDateStruct":208,"startDateStruct":7,"completionDateStruct":7,"leadSponsor":211,"locationsCount":212},{"fullName":5,"class":6},"Avidity Biosciences, Inc.","INDUSTRY",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":13},"DRUG","delpacibart zotadirsen","Del-zota is administered as an IV infusion every 6 weeks. Doses are administered based on body weight.",[14,15],"Del-zota","AOC 1044",[17],{"name":18,"role":19,"phone":20,"phoneExt":7,"email":21},"Clinigen Customer Service","CONTACT","1 877 768 4303","usmapcoordinators@clinigengroup.com",[23,37,47,57,66,75,85,95,105,115,124,134,144,154],{"facility":24,"status":25,"city":26,"state":27,"zip":28,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":7},"University of Alabama","AVAILABLE","Birmingham","Alabama","35294","United States","US",{"type":32,"coordinates":33},"Point",[34,35],-86.80249,33.52066,{"lat":35,"lon":34},{"facility":38,"status":25,"city":39,"state":40,"zip":41,"country":29,"countryCode":30,"cosmosGeoPoint":42,"geoPoint":46,"contacts":7},"Arkansas Children's Hospital","Little Rock","Arkansas","72202",{"type":32,"coordinates":43},[44,45],-92.28959,34.74648,{"lat":45,"lon":44},{"facility":48,"status":25,"city":49,"state":50,"zip":51,"country":29,"countryCode":30,"cosmosGeoPoint":52,"geoPoint":56,"contacts":7},"Rare Disease Research","Kissimmee","Florida","34746",{"type":32,"coordinates":53},[54,55],-81.41667,28.30468,{"lat":55,"lon":54},{"facility":58,"status":25,"city":59,"state":50,"zip":60,"country":29,"countryCode":30,"cosmosGeoPoint":61,"geoPoint":65,"contacts":7},"Nicklaus Children's Hospital","Miami","33155",{"type":32,"coordinates":62},[63,64],-80.19366,25.77427,{"lat":64,"lon":63},{"facility":48,"status":25,"city":67,"state":68,"zip":69,"country":29,"countryCode":30,"cosmosGeoPoint":70,"geoPoint":74,"contacts":7},"Atlanta","Georgia","30329",{"type":32,"coordinates":71},[72,73],-84.38798,33.749,{"lat":73,"lon":72},{"facility":76,"status":25,"city":77,"state":78,"zip":79,"country":29,"countryCode":30,"cosmosGeoPoint":80,"geoPoint":84,"contacts":7},"University of Kansas Medical Center","Kansas City","Kansas","66103",{"type":32,"coordinates":81},[82,83],-94.62746,39.11417,{"lat":83,"lon":82},{"facility":86,"status":25,"city":87,"state":88,"zip":89,"country":29,"countryCode":30,"cosmosGeoPoint":90,"geoPoint":94,"contacts":7},"UMass Memorial Health Care","Worcester","Massachusetts","01583",{"type":32,"coordinates":91},[92,93],-71.80229,42.26259,{"lat":93,"lon":92},{"facility":96,"status":25,"city":97,"state":98,"zip":99,"country":29,"countryCode":30,"cosmosGeoPoint":100,"geoPoint":104,"contacts":7},"Gillette Children's","Saint Paul","Minnesota","55101",{"type":32,"coordinates":101},[102,103],-93.09327,44.94441,{"lat":103,"lon":102},{"facility":106,"status":25,"city":107,"state":108,"zip":109,"country":29,"countryCode":30,"cosmosGeoPoint":110,"geoPoint":114,"contacts":7},"Washington University","St Louis","Missouri","63110",{"type":32,"coordinates":111},[112,113],-90.19789,38.62727,{"lat":113,"lon":112},{"facility":48,"status":25,"city":116,"state":117,"zip":118,"country":29,"countryCode":30,"cosmosGeoPoint":119,"geoPoint":123,"contacts":7},"Iselin","New Jersey","08830",{"type":32,"coordinates":120},[121,122],-74.32237,40.57538,{"lat":122,"lon":121},{"facility":125,"status":25,"city":126,"state":127,"zip":128,"country":29,"countryCode":30,"cosmosGeoPoint":129,"geoPoint":133,"contacts":7},"Nationwide Children's Hospital","Columbus","Ohio","43205",{"type":32,"coordinates":130},[131,132],-82.99879,39.96118,{"lat":132,"lon":131},{"facility":135,"status":25,"city":136,"state":137,"zip":138,"country":29,"countryCode":30,"cosmosGeoPoint":139,"geoPoint":143,"contacts":7},"University of Pennsylvania","Philadelphia","Pennsylvania","19104",{"type":32,"coordinates":140},[141,142],-75.16362,39.95238,{"lat":142,"lon":141},{"facility":145,"status":25,"city":146,"state":147,"zip":148,"country":29,"countryCode":30,"cosmosGeoPoint":149,"geoPoint":153,"contacts":7},"Prisma Health-Midlands Children's Hospital","Columbia","South Carolina","29203",{"type":32,"coordinates":150},[151,152],-81.03481,34.00071,{"lat":152,"lon":151},{"facility":155,"status":25,"city":156,"state":157,"zip":158,"country":29,"countryCode":30,"cosmosGeoPoint":159,"geoPoint":163,"contacts":7},"University of Vermont Medical Center","Burlington","Vermont","05401",{"type":32,"coordinates":160},[161,162],-73.21207,44.47588,{"lat":162,"lon":161},{"type":165,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[167],{"name":168,"class":169},"Clinigen Healthcare Limited","UNKNOWN","100612219","managed-access-program-for-del-zota-in-participants-with-dmd-mutations-amenable-to-exon-44-skipping-100612219",false,"NCT07250737","Managed Access Program for Del-zota in Participants With DMD Mutations Amenable to Exon 44 Skipping","Managed Access to Investigational Use of AOC 1044 in Participants With DMD Mutations Amenable to Exon 44 Skipping","Key Inclusion Criteria\n\nRollover Participants\n\n* Completed Study EXPLORE44-OLE Treatment Period (through W102)\n* No significant tolerability issues with AOC 1044\n\nNew (Non-Rollover) Participants\n\n* Permanently residing in the US and have a US primary health care provider\n* Documented dystrophin gene mutation that is amenable to exon 44 skipping\n* Age 2 or older at the time of consent\n* If previously treated with gene therapy for DMD, treatment and associated immunosuppressive regimen was more than 12 months before consent and in the opinion of the prescriber, participant has had an unsatisfactory treatment response\n\nKey Exclusion Criteria\n\nRollover Participants\n\n• Prescence of any new condition or worsening of existing condition that could affect participant's safety or ability to comply with the program requirements\n\nNew (Non-Rollover) Participants\n\n* Recently treated with or on a clinical study for another investigation drug\n* Serious respiratory or cardiac dysfunction, or nearing end of life\n* Screening laboratory parameters do not meet protocol requirements\n* History of multiple drug allergies or to any component of AOC 1044\n* Participants who discontinued early from the treatment period of EXPLORE44 or EXPLORE44-OLE","MALE","2 Years","EXPANDED_ACCESS","The purpose of this Managed Access Program is to allow access to delpacibart zotadirsen (AOC 1044) for eligible patients diagnosed with DMD mutations amenable to exon 44 skipping. The patient's Administering Physician should follow the suggested treatment guidelines and comply with all local health authority regulations.",[182,183,184,185,186,187,188,189,190],"Muscular Disorders, Atrophic","Muscular Diseases","Musculoskeletal Diseases","Neuromuscular Diseases","Nervous System Diseases","Genetic Diseases, Inborn","Genetic Diseases, X-Linked","Muscular Dystrophies","Muscular Dystrophy, Duchenne",[192,193,15,194,195,196,197,14,11,198,199,200,201,202,203,204,205,206],"Avidity","Avidity Biosciences","AOC 1044-CS1","AOC 1044-CS2","EXPLORE44","EXPLORE44-OLE","DMD","exon skipping therapy","dystrophin","managed access","expanded access","pre-approval access","compassionate use","MAP","EAP","2026-06-26",{"date":209,"type":210},"2026-06-29","ACTUAL",{"name":5,"class":6},14]